Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21WAF1/CIP1 via C/EBPβ
- 1 November 1997
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 3 (11), 1233-1241
- https://doi.org/10.1038/nm1197-1233
Abstract
Colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States. Five-fluorouracil (5FU) remains the single most effective treatment for advanced disease, despite a response rate of only 20%. Herein, we show that the antioxidants pyrrolidinedithiocarbamate and vitamin E induce apoptosis in CRC cells. This effect is mediated by induction of p21WAF1/CIP1, a powerful inhibitor of the cell cycle, through a mechanism involving C/EBPbeta (a member of the CCAAT/enhancer binding protein family of transcription factors), independent of p53. Antioxidants significantly enhance CRC tumor growth inhibition by cytotoxic chemotherapy in vitro (5FU and doxorubicin) and in vivo (5FU). Thus, chemotherapeutic agents administered in the presence of antioxidants may provide a novel therapy for colorectal cancer.Keywords
This publication has 50 references indexed in Scilit:
- Mitogenic Signaling Mediated by Oxidants in Ras-Transformed FibroblastsScience, 1997
- Protective Role of p21Waf1/Cip1 against Prostaglandin A2-Mediated Apoptosis of Human Colorectal Carcinoma CellsMolecular and Cellular Biology, 1996
- Role of E6 and E7 oncoproteins in HPV-induced anogenital malignanciesSeminars in Virology, 1996
- Thymidylate synthase and drug resistanceEuropean Journal Of Cancer, 1995
- p53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell, 1993
- Dietary Carotenes, Vitamin C, and Vitamin E as Protective Antioxidants in Human CancersAnnual Review of Nutrition, 1992
- The p53 tumour suppressor geneNature, 1991
- The molecular pharmacology of doxorubicin in vivoEuropean Journal of Cancer and Clinical Oncology, 1991
- Biochemical modulation of 5-fluorouracilCancer Treatment Reviews, 1990
- The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53Cell, 1990